Other Species / Isoforms
  IEX-1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T18-p
MTILQAPtPAPSTIP
Upstream
Downstream
1 2
Effects on Biological Processes:
  • apoptosis, inhibited
Kinase, in vitro:
  • ERK2 (human)
Putative in vivo kinases:
  • ERK2 (human)
Treatment
  • PD98059
  • TPO
IEX-1 (human) MTILQAPtPAPSTIP T18-p
IEX-1 (mouse) MTGLRAPsPAPSTGP S18-p
S31-p
IPGPRRGsGPEIFTF
Upstream
0 15
Treatment
  • selumetinib
  • vemurafenib
IEX-1 (human) IPGPRRGsGPEIFTF S31-p
IEX-1 (mouse) GPELRRGsGPEIFTF S31-p
S53-p
AAPAGRPsAsRGHRK
0 1
IEX-1 (human) AAPAGRPsAsRGHRK S53-p
IEX-1 (mouse) VVSTARLNTSRGHRK N53
S55-p
PAGRPsAsRGHRKRS
0 1
IEX-1 (human) PAGRPsAsRGHRKRS S55-p
IEX-1 (mouse) STARLNTSRGHRKRS S55
K84-ub
VEEPNPAkRLLFLLL
0 2
IEX-1 (human) VEEPNPAkRLLFLLL K84-ub
IEX-1 (mouse) TEEPNIAKRVLFLLF K84